Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Pilot study of Bexxar in advanced previously heavily treated refractory chronic lymphocytic leukemia (CLL). Gupta, N. K., Cao, T. M., French, J. N., Goris, M. L., Capizi, R., Califano, J., Palestro, C. J., Rai, K. R., Coutre, S. E. AMER SOC HEMATOLOGY. 2001: 290B–290B
View details for Web of Science ID 000172134201315